nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—HTR2C—type 2 diabetes mellitus	0.254	0.667	CbGaD
Tramadol—CYP3A4—type 2 diabetes mellitus	0.127	0.333	CbGaD
Tramadol—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0559	0.188	CbGbCtD
Tramadol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0244	0.0821	CbGbCtD
Tramadol—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0241	0.081	CbGbCtD
Tramadol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0225	0.0758	CbGbCtD
Tramadol—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0214	0.0722	CbGbCtD
Tramadol—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0196	0.0661	CbGbCtD
Tramadol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0185	0.0622	CbGbCtD
Tramadol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0177	0.0597	CbGbCtD
Tramadol—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0171	0.0577	CbGbCtD
Tramadol—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0155	0.0522	CbGbCtD
Tramadol—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0117	0.0396	CbGbCtD
Tramadol—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0113	0.0379	CbGbCtD
Tramadol—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0113	0.0379	CbGbCtD
Tramadol—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0106	0.0359	CbGbCtD
Tramadol—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00793	0.0267	CbGbCtD
Tramadol—CYP3A4—Losartan—type 2 diabetes mellitus	0.00726	0.0245	CbGbCtD
Tramadol—Venlafaxine—CYP3A4—type 2 diabetes mellitus	0.00052	0.469	CrCbGaD
Tramadol—Dextromethorphan—CYP2E1—type 2 diabetes mellitus	0.000361	0.326	CrCbGaD
Tramadol—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.000349	0.272	CbGeAlD
Tramadol—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.000235	0.183	CbGeAlD
Tramadol—Dextromethorphan—CYP3A4—type 2 diabetes mellitus	0.000228	0.205	CrCbGaD
Tramadol—OPRM1—nerve—type 2 diabetes mellitus	0.00018	0.141	CbGeAlD
Tramadol—SLC6A2—nerve—type 2 diabetes mellitus	0.000132	0.103	CbGeAlD
Tramadol—OPRD1—kidney—type 2 diabetes mellitus	9.06e-05	0.0707	CbGeAlD
Tramadol—Insomnia—Orlistat—type 2 diabetes mellitus	5.11e-05	0.000213	CcSEcCtD
Tramadol—Malaise—Losartan—type 2 diabetes mellitus	5.11e-05	0.000213	CcSEcCtD
Tramadol—Anxiety—Irbesartan—type 2 diabetes mellitus	5.11e-05	0.000213	CcSEcCtD
Tramadol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.11e-05	0.000213	CcSEcCtD
Tramadol—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.11e-05	0.000213	CcSEcCtD
Tramadol—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.1e-05	0.000213	CcSEcCtD
Tramadol—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.1e-05	0.000213	CcSEcCtD
Tramadol—Vertigo—Losartan—type 2 diabetes mellitus	5.09e-05	0.000212	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000212	CcSEcCtD
Tramadol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.09e-05	0.000212	CcSEcCtD
Tramadol—Somnolence—Valsartan—type 2 diabetes mellitus	5.09e-05	0.000212	CcSEcCtD
Tramadol—Syncope—Losartan—type 2 diabetes mellitus	5.09e-05	0.000212	CcSEcCtD
Tramadol—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.08e-05	0.000212	CcSEcCtD
Tramadol—Discomfort—Irbesartan—type 2 diabetes mellitus	5.07e-05	0.000211	CcSEcCtD
Tramadol—Skin disorder—Metformin—type 2 diabetes mellitus	5.06e-05	0.000211	CcSEcCtD
Tramadol—Immune system disorder—Ramipril—type 2 diabetes mellitus	5.05e-05	0.00021	CcSEcCtD
Tramadol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	5.04e-05	0.00021	CcSEcCtD
Tramadol—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.04e-05	0.00021	CcSEcCtD
Tramadol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	5.03e-05	0.00021	CcSEcCtD
Tramadol—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.02e-05	0.000209	CcSEcCtD
Tramadol—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.02e-05	0.000209	CcSEcCtD
Tramadol—Palpitations—Losartan—type 2 diabetes mellitus	5.01e-05	0.000209	CcSEcCtD
Tramadol—Nausea—Glimepiride—type 2 diabetes mellitus	5e-05	0.000208	CcSEcCtD
Tramadol—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000208	CcSEcCtD
Tramadol—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.98e-05	0.000208	CcSEcCtD
Tramadol—Nausea—Sitagliptin—type 2 diabetes mellitus	4.98e-05	0.000208	CcSEcCtD
Tramadol—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.98e-05	0.000207	CcSEcCtD
Tramadol—Asthenia—Glyburide—type 2 diabetes mellitus	4.98e-05	0.000207	CcSEcCtD
Tramadol—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.97e-05	0.000207	CcSEcCtD
Tramadol—Anorexia—Metformin—type 2 diabetes mellitus	4.97e-05	0.000207	CcSEcCtD
Tramadol—Cough—Losartan—type 2 diabetes mellitus	4.95e-05	0.000206	CcSEcCtD
Tramadol—Urticaria—Gliclazide—type 2 diabetes mellitus	4.95e-05	0.000206	CcSEcCtD
Tramadol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.94e-05	0.000206	CcSEcCtD
Tramadol—Fatigue—Valsartan—type 2 diabetes mellitus	4.93e-05	0.000206	CcSEcCtD
Tramadol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.92e-05	0.000205	CcSEcCtD
Tramadol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.92e-05	0.000205	CcSEcCtD
Tramadol—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000205	CcSEcCtD
Tramadol—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.92e-05	0.000205	CcSEcCtD
Tramadol—Pruritus—Glyburide—type 2 diabetes mellitus	4.91e-05	0.000204	CcSEcCtD
Tramadol—Mental disorder—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000204	CcSEcCtD
Tramadol—Constipation—Valsartan—type 2 diabetes mellitus	4.89e-05	0.000204	CcSEcCtD
Tramadol—Infection—Irbesartan—type 2 diabetes mellitus	4.89e-05	0.000204	CcSEcCtD
Tramadol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.88e-05	0.000203	CcSEcCtD
Tramadol—Fatigue—Orlistat—type 2 diabetes mellitus	4.88e-05	0.000203	CcSEcCtD
Tramadol—Hypotension—Metformin—type 2 diabetes mellitus	4.87e-05	0.000203	CcSEcCtD
Tramadol—Malnutrition—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000203	CcSEcCtD
Tramadol—Erythema—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000203	CcSEcCtD
Tramadol—Shock—Irbesartan—type 2 diabetes mellitus	4.84e-05	0.000202	CcSEcCtD
Tramadol—Pain—Orlistat—type 2 diabetes mellitus	4.84e-05	0.000201	CcSEcCtD
Tramadol—Chest pain—Losartan—type 2 diabetes mellitus	4.83e-05	0.000201	CcSEcCtD
Tramadol—Arthralgia—Losartan—type 2 diabetes mellitus	4.83e-05	0.000201	CcSEcCtD
Tramadol—Myalgia—Losartan—type 2 diabetes mellitus	4.83e-05	0.000201	CcSEcCtD
Tramadol—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.82e-05	0.000201	CcSEcCtD
Tramadol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.82e-05	0.000201	CcSEcCtD
Tramadol—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.82e-05	0.000201	CcSEcCtD
Tramadol—Anxiety—Losartan—type 2 diabetes mellitus	4.81e-05	0.0002	CcSEcCtD
Tramadol—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.0002	CcSEcCtD
Tramadol—Rash—Bromocriptine—type 2 diabetes mellitus	4.78e-05	0.000199	CcSEcCtD
Tramadol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.78e-05	0.000199	CcSEcCtD
Tramadol—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.78e-05	0.000199	CcSEcCtD
Tramadol—Tension—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000199	CcSEcCtD
Tramadol—Discomfort—Losartan—type 2 diabetes mellitus	4.77e-05	0.000199	CcSEcCtD
Tramadol—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000198	CcSEcCtD
Tramadol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.75e-05	0.000198	CcSEcCtD
Tramadol—Headache—Bromocriptine—type 2 diabetes mellitus	4.75e-05	0.000198	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.75e-05	0.000198	CcSEcCtD
Tramadol—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.75e-05	0.000198	CcSEcCtD
Tramadol—Nervousness—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000197	CcSEcCtD
Tramadol—Dry mouth—Losartan—type 2 diabetes mellitus	4.72e-05	0.000197	CcSEcCtD
Tramadol—Anorexia—Irbesartan—type 2 diabetes mellitus	4.69e-05	0.000195	CcSEcCtD
Tramadol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.68e-05	0.000195	CcSEcCtD
Tramadol—Paraesthesia—Metformin—type 2 diabetes mellitus	4.68e-05	0.000195	CcSEcCtD
Tramadol—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000195	CcSEcCtD
Tramadol—Confusional state—Losartan—type 2 diabetes mellitus	4.67e-05	0.000194	CcSEcCtD
Tramadol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.66e-05	0.000194	CcSEcCtD
Tramadol—Dyspnoea—Metformin—type 2 diabetes mellitus	4.65e-05	0.000194	CcSEcCtD
Tramadol—Somnolence—Metformin—type 2 diabetes mellitus	4.63e-05	0.000193	CcSEcCtD
Tramadol—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.63e-05	0.000193	CcSEcCtD
Tramadol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.62e-05	0.000193	CcSEcCtD
Tramadol—Infection—Losartan—type 2 diabetes mellitus	4.6e-05	0.000192	CcSEcCtD
Tramadol—Hypotension—Irbesartan—type 2 diabetes mellitus	4.6e-05	0.000191	CcSEcCtD
Tramadol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.59e-05	0.000191	CcSEcCtD
Tramadol—Dyspepsia—Metformin—type 2 diabetes mellitus	4.59e-05	0.000191	CcSEcCtD
Tramadol—CHRM3—kidney—type 2 diabetes mellitus	4.58e-05	0.0357	CbGeAlD
Tramadol—Tremor—Ramipril—type 2 diabetes mellitus	4.56e-05	0.00019	CcSEcCtD
Tramadol—Shock—Losartan—type 2 diabetes mellitus	4.55e-05	0.00019	CcSEcCtD
Tramadol—Urticaria—Valsartan—type 2 diabetes mellitus	4.55e-05	0.000189	CcSEcCtD
Tramadol—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.54e-05	0.000189	CcSEcCtD
Tramadol—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.53e-05	0.000189	CcSEcCtD
Tramadol—Decreased appetite—Metformin—type 2 diabetes mellitus	4.53e-05	0.000189	CcSEcCtD
Tramadol—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.52e-05	0.000188	CcSEcCtD
Tramadol—Tachycardia—Losartan—type 2 diabetes mellitus	4.52e-05	0.000188	CcSEcCtD
Tramadol—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000188	CcSEcCtD
Tramadol—Nausea—Bromocriptine—type 2 diabetes mellitus	4.51e-05	0.000188	CcSEcCtD
Tramadol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.5e-05	0.000187	CcSEcCtD
Tramadol—Fatigue—Metformin—type 2 diabetes mellitus	4.49e-05	0.000187	CcSEcCtD
Tramadol—Urticaria—Orlistat—type 2 diabetes mellitus	4.49e-05	0.000187	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.48e-05	0.000187	CcSEcCtD
Tramadol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.47e-05	0.000186	CcSEcCtD
Tramadol—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.47e-05	0.000186	CcSEcCtD
Tramadol—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.47e-05	0.000186	CcSEcCtD
Tramadol—Asthenia—Gliclazide—type 2 diabetes mellitus	4.47e-05	0.000186	CcSEcCtD
Tramadol—Agitation—Ramipril—type 2 diabetes mellitus	4.47e-05	0.000186	CcSEcCtD
Tramadol—Constipation—Metformin—type 2 diabetes mellitus	4.46e-05	0.000186	CcSEcCtD
Tramadol—Angioedema—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000185	CcSEcCtD
Tramadol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000184	CcSEcCtD
Tramadol—Anorexia—Losartan—type 2 diabetes mellitus	4.41e-05	0.000184	CcSEcCtD
Tramadol—Vomiting—Glyburide—type 2 diabetes mellitus	4.41e-05	0.000184	CcSEcCtD
Tramadol—Pruritus—Gliclazide—type 2 diabetes mellitus	4.41e-05	0.000184	CcSEcCtD
Tramadol—Malaise—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000183	CcSEcCtD
Tramadol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.38e-05	0.000183	CcSEcCtD
Tramadol—Rash—Glyburide—type 2 diabetes mellitus	4.37e-05	0.000182	CcSEcCtD
Tramadol—Somnolence—Irbesartan—type 2 diabetes mellitus	4.37e-05	0.000182	CcSEcCtD
Tramadol—Dermatitis—Glyburide—type 2 diabetes mellitus	4.37e-05	0.000182	CcSEcCtD
Tramadol—Vertigo—Ramipril—type 2 diabetes mellitus	4.37e-05	0.000182	CcSEcCtD
Tramadol—Syncope—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000182	CcSEcCtD
Tramadol—Headache—Glyburide—type 2 diabetes mellitus	4.35e-05	0.000181	CcSEcCtD
Tramadol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.33e-05	0.00018	CcSEcCtD
Tramadol—Hypotension—Losartan—type 2 diabetes mellitus	4.32e-05	0.00018	CcSEcCtD
Tramadol—Palpitations—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000179	CcSEcCtD
Tramadol—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.29e-05	0.000179	CcSEcCtD
Tramadol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.27e-05	0.000178	CcSEcCtD
Tramadol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000178	CcSEcCtD
Tramadol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.26e-05	0.000178	CcSEcCtD
Tramadol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.26e-05	0.000178	CcSEcCtD
Tramadol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.25e-05	0.000177	CcSEcCtD
Tramadol—Cough—Ramipril—type 2 diabetes mellitus	4.24e-05	0.000177	CcSEcCtD
Tramadol—Fatigue—Irbesartan—type 2 diabetes mellitus	4.24e-05	0.000177	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.22e-05	0.000176	CcSEcCtD
Tramadol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.22e-05	0.000176	CcSEcCtD
Tramadol—Convulsion—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000176	CcSEcCtD
Tramadol—Pain—Irbesartan—type 2 diabetes mellitus	4.21e-05	0.000175	CcSEcCtD
Tramadol—Constipation—Irbesartan—type 2 diabetes mellitus	4.21e-05	0.000175	CcSEcCtD
Tramadol—Insomnia—Losartan—type 2 diabetes mellitus	4.19e-05	0.000174	CcSEcCtD
Tramadol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.17e-05	0.000174	CcSEcCtD
Tramadol—Paraesthesia—Losartan—type 2 diabetes mellitus	4.16e-05	0.000173	CcSEcCtD
Tramadol—Urticaria—Metformin—type 2 diabetes mellitus	4.14e-05	0.000173	CcSEcCtD
Tramadol—Chest pain—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000172	CcSEcCtD
Tramadol—Myalgia—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000172	CcSEcCtD
Tramadol—Arthralgia—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000172	CcSEcCtD
Tramadol—CHRM3—adipose tissue—type 2 diabetes mellitus	4.13e-05	0.0322	CbGeAlD
Tramadol—Dyspnoea—Losartan—type 2 diabetes mellitus	4.13e-05	0.000172	CcSEcCtD
Tramadol—Anxiety—Ramipril—type 2 diabetes mellitus	4.13e-05	0.000172	CcSEcCtD
Tramadol—Nausea—Glyburide—type 2 diabetes mellitus	4.12e-05	0.000172	CcSEcCtD
Tramadol—Abdominal pain—Metformin—type 2 diabetes mellitus	4.12e-05	0.000172	CcSEcCtD
Tramadol—Dizziness—Gliclazide—type 2 diabetes mellitus	4.12e-05	0.000172	CcSEcCtD
Tramadol—Somnolence—Losartan—type 2 diabetes mellitus	4.11e-05	0.000171	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000171	CcSEcCtD
Tramadol—Asthenia—Valsartan—type 2 diabetes mellitus	4.11e-05	0.000171	CcSEcCtD
Tramadol—Discomfort—Ramipril—type 2 diabetes mellitus	4.09e-05	0.00017	CcSEcCtD
Tramadol—Dyspepsia—Losartan—type 2 diabetes mellitus	4.07e-05	0.00017	CcSEcCtD
Tramadol—Asthenia—Orlistat—type 2 diabetes mellitus	4.06e-05	0.000169	CcSEcCtD
Tramadol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.05e-05	0.000169	CcSEcCtD
Tramadol—Pruritus—Valsartan—type 2 diabetes mellitus	4.05e-05	0.000169	CcSEcCtD
Tramadol—Dry mouth—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000169	CcSEcCtD
Tramadol—Decreased appetite—Losartan—type 2 diabetes mellitus	4.02e-05	0.000168	CcSEcCtD
Tramadol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.02e-05	0.000168	CcSEcCtD
Tramadol—Confusional state—Ramipril—type 2 diabetes mellitus	4e-05	0.000167	CcSEcCtD
Tramadol—Pruritus—Orlistat—type 2 diabetes mellitus	4e-05	0.000167	CcSEcCtD
Tramadol—Fatigue—Losartan—type 2 diabetes mellitus	3.99e-05	0.000166	CcSEcCtD
Tramadol—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000165	CcSEcCtD
Tramadol—Vomiting—Gliclazide—type 2 diabetes mellitus	3.96e-05	0.000165	CcSEcCtD
Tramadol—Constipation—Losartan—type 2 diabetes mellitus	3.96e-05	0.000165	CcSEcCtD
Tramadol—Pain—Losartan—type 2 diabetes mellitus	3.96e-05	0.000165	CcSEcCtD
Tramadol—Rash—Gliclazide—type 2 diabetes mellitus	3.93e-05	0.000164	CcSEcCtD
Tramadol—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.92e-05	0.000163	CcSEcCtD
Tramadol—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.92e-05	0.000163	CcSEcCtD
Tramadol—Urticaria—Irbesartan—type 2 diabetes mellitus	3.91e-05	0.000163	CcSEcCtD
Tramadol—Shock—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000163	CcSEcCtD
Tramadol—Headache—Gliclazide—type 2 diabetes mellitus	3.9e-05	0.000163	CcSEcCtD
Tramadol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000162	CcSEcCtD
Tramadol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.000162	CcSEcCtD
Tramadol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.000162	CcSEcCtD
Tramadol—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000162	CcSEcCtD
Tramadol—Tachycardia—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000161	CcSEcCtD
Tramadol—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.87e-05	0.000161	CcSEcCtD
Tramadol—Skin disorder—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000161	CcSEcCtD
Tramadol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.84e-05	0.00016	CcSEcCtD
Tramadol—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.81e-05	0.000159	CcSEcCtD
Tramadol—CYP2B6—nephron tubule—type 2 diabetes mellitus	3.79e-05	0.0296	CbGeAlD
Tramadol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.78e-05	0.000158	CcSEcCtD
Tramadol—Dizziness—Valsartan—type 2 diabetes mellitus	3.78e-05	0.000158	CcSEcCtD
Tramadol—Anorexia—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000158	CcSEcCtD
Tramadol—Dizziness—Orlistat—type 2 diabetes mellitus	3.74e-05	0.000156	CcSEcCtD
Tramadol—Asthenia—Metformin—type 2 diabetes mellitus	3.74e-05	0.000156	CcSEcCtD
Tramadol—Hypotension—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000155	CcSEcCtD
Tramadol—Nausea—Gliclazide—type 2 diabetes mellitus	3.7e-05	0.000154	CcSEcCtD
Tramadol—Pruritus—Metformin—type 2 diabetes mellitus	3.69e-05	0.000154	CcSEcCtD
Tramadol—Urticaria—Losartan—type 2 diabetes mellitus	3.68e-05	0.000153	CcSEcCtD
Tramadol—Abdominal pain—Losartan—type 2 diabetes mellitus	3.66e-05	0.000152	CcSEcCtD
Tramadol—Body temperature increased—Losartan—type 2 diabetes mellitus	3.66e-05	0.000152	CcSEcCtD
Tramadol—Vomiting—Valsartan—type 2 diabetes mellitus	3.64e-05	0.000152	CcSEcCtD
Tramadol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.62e-05	0.000151	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000151	CcSEcCtD
Tramadol—Rash—Valsartan—type 2 diabetes mellitus	3.61e-05	0.00015	CcSEcCtD
Tramadol—Dermatitis—Valsartan—type 2 diabetes mellitus	3.6e-05	0.00015	CcSEcCtD
Tramadol—Vomiting—Orlistat—type 2 diabetes mellitus	3.6e-05	0.00015	CcSEcCtD
Tramadol—Insomnia—Ramipril—type 2 diabetes mellitus	3.59e-05	0.00015	CcSEcCtD
Tramadol—Headache—Valsartan—type 2 diabetes mellitus	3.58e-05	0.000149	CcSEcCtD
Tramadol—Diarrhoea—Metformin—type 2 diabetes mellitus	3.57e-05	0.000149	CcSEcCtD
Tramadol—Rash—Orlistat—type 2 diabetes mellitus	3.57e-05	0.000149	CcSEcCtD
Tramadol—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.56e-05	0.000148	CcSEcCtD
Tramadol—Dermatitis—Orlistat—type 2 diabetes mellitus	3.56e-05	0.000148	CcSEcCtD
Tramadol—Headache—Orlistat—type 2 diabetes mellitus	3.54e-05	0.000148	CcSEcCtD
Tramadol—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000147	CcSEcCtD
Tramadol—Asthenia—Irbesartan—type 2 diabetes mellitus	3.53e-05	0.000147	CcSEcCtD
Tramadol—Somnolence—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000147	CcSEcCtD
Tramadol—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000146	CcSEcCtD
Tramadol—Pruritus—Irbesartan—type 2 diabetes mellitus	3.48e-05	0.000145	CcSEcCtD
Tramadol—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.45e-05	0.000144	CcSEcCtD
Tramadol—Dizziness—Metformin—type 2 diabetes mellitus	3.45e-05	0.000144	CcSEcCtD
Tramadol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000143	CcSEcCtD
Tramadol—Fatigue—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000143	CcSEcCtD
Tramadol—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.41e-05	0.000142	CcSEcCtD
Tramadol—CYP2B6—cardiovascular system—type 2 diabetes mellitus	3.41e-05	0.0266	CbGeAlD
Tramadol—Nausea—Valsartan—type 2 diabetes mellitus	3.4e-05	0.000142	CcSEcCtD
Tramadol—Constipation—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000141	CcSEcCtD
Tramadol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.36e-05	0.00014	CcSEcCtD
Tramadol—Nausea—Orlistat—type 2 diabetes mellitus	3.36e-05	0.00014	CcSEcCtD
Tramadol—CYP2B6—kidney—type 2 diabetes mellitus	3.33e-05	0.026	CbGeAlD
Tramadol—Asthenia—Losartan—type 2 diabetes mellitus	3.32e-05	0.000138	CcSEcCtD
Tramadol—Vomiting—Metformin—type 2 diabetes mellitus	3.31e-05	0.000138	CcSEcCtD
Tramadol—Rash—Metformin—type 2 diabetes mellitus	3.29e-05	0.000137	CcSEcCtD
Tramadol—Dermatitis—Metformin—type 2 diabetes mellitus	3.28e-05	0.000137	CcSEcCtD
Tramadol—Pruritus—Losartan—type 2 diabetes mellitus	3.27e-05	0.000136	CcSEcCtD
Tramadol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000136	CcSEcCtD
Tramadol—Headache—Metformin—type 2 diabetes mellitus	3.26e-05	0.000136	CcSEcCtD
Tramadol—Dizziness—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000136	CcSEcCtD
Tramadol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000135	CcSEcCtD
Tramadol—Diarrhoea—Losartan—type 2 diabetes mellitus	3.17e-05	0.000132	CcSEcCtD
Tramadol—Urticaria—Ramipril—type 2 diabetes mellitus	3.15e-05	0.000131	CcSEcCtD
Tramadol—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000131	CcSEcCtD
Tramadol—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000131	CcSEcCtD
Tramadol—Vomiting—Irbesartan—type 2 diabetes mellitus	3.13e-05	0.00013	CcSEcCtD
Tramadol—Rash—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.000129	CcSEcCtD
Tramadol—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.000129	CcSEcCtD
Tramadol—Nausea—Metformin—type 2 diabetes mellitus	3.1e-05	0.000129	CcSEcCtD
Tramadol—Headache—Irbesartan—type 2 diabetes mellitus	3.08e-05	0.000128	CcSEcCtD
Tramadol—Dizziness—Losartan—type 2 diabetes mellitus	3.06e-05	0.000128	CcSEcCtD
Tramadol—Vomiting—Losartan—type 2 diabetes mellitus	2.94e-05	0.000123	CcSEcCtD
Tramadol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.92e-05	0.000122	CcSEcCtD
Tramadol—Nausea—Irbesartan—type 2 diabetes mellitus	2.92e-05	0.000122	CcSEcCtD
Tramadol—Rash—Losartan—type 2 diabetes mellitus	2.92e-05	0.000122	CcSEcCtD
Tramadol—Dermatitis—Losartan—type 2 diabetes mellitus	2.92e-05	0.000121	CcSEcCtD
Tramadol—Headache—Losartan—type 2 diabetes mellitus	2.9e-05	0.000121	CcSEcCtD
Tramadol—Asthenia—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000119	CcSEcCtD
Tramadol—Pruritus—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000117	CcSEcCtD
Tramadol—Nausea—Losartan—type 2 diabetes mellitus	2.75e-05	0.000115	CcSEcCtD
Tramadol—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.72e-05	0.000113	CcSEcCtD
Tramadol—Dizziness—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000109	CcSEcCtD
Tramadol—Vomiting—Ramipril—type 2 diabetes mellitus	2.52e-05	0.000105	CcSEcCtD
Tramadol—CYP3A4—kidney—type 2 diabetes mellitus	2.52e-05	0.0196	CbGeAlD
Tramadol—Rash—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000104	CcSEcCtD
Tramadol—Dermatitis—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000104	CcSEcCtD
Tramadol—Headache—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000104	CcSEcCtD
Tramadol—CYP2D6—kidney—type 2 diabetes mellitus	2.48e-05	0.0193	CbGeAlD
Tramadol—Nausea—Ramipril—type 2 diabetes mellitus	2.36e-05	9.82e-05	CcSEcCtD
Tramadol—CYP2B6—liver—type 2 diabetes mellitus	2.11e-05	0.0164	CbGeAlD
Tramadol—CYP3A4—liver—type 2 diabetes mellitus	1.59e-05	0.0124	CbGeAlD
Tramadol—CYP2D6—liver—type 2 diabetes mellitus	1.57e-05	0.0122	CbGeAlD
Tramadol—HTR2C—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.13e-06	7.69e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	6.09e-06	7.65e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.09e-06	7.65e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.07e-06	7.61e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.07e-06	7.61e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	6.06e-06	7.6e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	6.05e-06	7.6e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.04e-06	7.58e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.02e-06	7.55e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.01e-06	7.55e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6e-06	7.53e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.98e-06	7.5e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	5.94e-06	7.46e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.92e-06	7.43e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	5.91e-06	7.42e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	5.91e-06	7.42e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	5.91e-06	7.42e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	5.89e-06	7.4e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	5.89e-06	7.39e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—C3—type 2 diabetes mellitus	5.88e-06	7.38e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.86e-06	7.36e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.8e-06	7.28e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.8e-06	7.27e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	5.79e-06	7.26e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	5.75e-06	7.22e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.75e-06	7.22e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.69e-06	7.14e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	5.66e-06	7.11e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	5.66e-06	7.1e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.65e-06	7.09e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.65e-06	7.09e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	5.64e-06	7.08e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	5.64e-06	7.08e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.63e-06	7.06e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	5.62e-06	7.06e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.61e-06	7.05e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.61e-06	7.04e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.59e-06	7.02e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AGT—type 2 diabetes mellitus	5.59e-06	7.01e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	5.57e-06	6.99e-05	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.52e-06	6.93e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.5e-06	6.91e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	5.5e-06	6.9e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.49e-06	6.9e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—LEP—type 2 diabetes mellitus	5.47e-06	6.87e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APOE—type 2 diabetes mellitus	5.47e-06	6.87e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.47e-06	6.87e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	5.45e-06	6.84e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.44e-06	6.82e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.43e-06	6.81e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.42e-06	6.81e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.42e-06	6.81e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.42e-06	6.81e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.42e-06	6.81e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.41e-06	6.79e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.41e-06	6.78e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.36e-06	6.73e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.34e-06	6.71e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.34e-06	6.71e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.32e-06	6.68e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.28e-06	6.62e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.27e-06	6.61e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.26e-06	6.61e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.24e-06	6.58e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.21e-06	6.54e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	5.21e-06	6.54e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.2e-06	6.53e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.18e-06	6.5e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.17e-06	6.49e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.16e-06	6.48e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.12e-06	6.43e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.12e-06	6.43e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.12e-06	6.42e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	5.11e-06	6.41e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	5.06e-06	6.35e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.01e-06	6.29e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5e-06	6.28e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	4.95e-06	6.21e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	4.91e-06	6.16e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.88e-06	6.13e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	4.87e-06	6.11e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	4.85e-06	6.09e-05	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.84e-06	6.08e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.83e-06	6.07e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.83e-06	6.06e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.82e-06	6.05e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—INS—type 2 diabetes mellitus	4.82e-06	6.04e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	4.81e-06	6.04e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.8e-06	6.02e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	4.79e-06	6.02e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.78e-06	5.99e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.78e-06	5.99e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.77e-06	5.98e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.77e-06	5.98e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.73e-06	5.94e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	4.71e-06	5.92e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	4.71e-06	5.92e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—INS—type 2 diabetes mellitus	4.68e-06	5.87e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.66e-06	5.85e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.64e-06	5.83e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.6e-06	5.78e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.53e-06	5.69e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.52e-06	5.68e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.52e-06	5.67e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.51e-06	5.66e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.5e-06	5.65e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.5e-06	5.64e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.49e-06	5.63e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.44e-06	5.58e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.42e-06	5.55e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.42e-06	5.55e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.42e-06	5.54e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.42e-06	5.54e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	4.41e-06	5.54e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.4e-06	5.52e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.4e-06	5.52e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.34e-06	5.44e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.34e-06	5.44e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.31e-06	5.41e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.31e-06	5.41e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.31e-06	5.41e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.3e-06	5.39e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.28e-06	5.37e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.26e-06	5.35e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	4.22e-06	5.3e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	4.22e-06	5.3e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	4.22e-06	5.3e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.21e-06	5.29e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.2e-06	5.28e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.2e-06	5.28e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.18e-06	5.25e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.18e-06	5.24e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.16e-06	5.22e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	4.14e-06	5.2e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.1e-06	5.15e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.1e-06	5.15e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.1e-06	5.14e-05	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.09e-06	5.14e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.07e-06	5.11e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.05e-06	5.09e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.03e-06	5.06e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	4.03e-06	5.05e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.02e-06	5.05e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.96e-06	4.97e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.94e-06	4.94e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.92e-06	4.92e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.89e-06	4.89e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.89e-06	4.89e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.88e-06	4.86e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.86e-06	4.85e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.86e-06	4.85e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.86e-06	4.85e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	3.86e-06	4.85e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	3.86e-06	4.85e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.83e-06	4.81e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.82e-06	4.8e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	3.8e-06	4.77e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.79e-06	4.76e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.79e-06	4.76e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.77e-06	4.74e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.76e-06	4.72e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.74e-06	4.69e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.72e-06	4.66e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.7e-06	4.64e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.68e-06	4.62e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.66e-06	4.6e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.63e-06	4.56e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.63e-06	4.56e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.62e-06	4.54e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.55e-06	4.46e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.53e-06	4.44e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.53e-06	4.43e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.53e-06	4.43e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.53e-06	4.43e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.51e-06	4.41e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.49e-06	4.39e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.49e-06	4.39e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.48e-06	4.37e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.46e-06	4.34e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.44e-06	4.32e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.44e-06	4.32e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.38e-06	4.25e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.37e-06	4.23e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.35e-06	4.21e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.35e-06	4.21e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.33e-06	4.18e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	3.32e-06	4.17e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	3.32e-06	4.17e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.29e-06	4.13e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.26e-06	4.09e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.21e-06	4.03e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.19e-06	4.01e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.16e-06	3.96e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.1e-06	3.89e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	3.03e-06	3.81e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.03e-06	3.8e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	3e-06	3.76e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.98e-06	3.74e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.96e-06	3.72e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.95e-06	3.71e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.94e-06	3.68e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.89e-06	3.62e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.89e-06	3.62e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.88e-06	3.61e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.87e-06	3.61e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.84e-06	3.56e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.83e-06	3.56e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.82e-06	3.53e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.8e-06	3.52e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.75e-06	3.46e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.75e-06	3.45e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.71e-06	3.4e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.68e-06	3.36e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.66e-06	3.34e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.64e-06	3.31e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.63e-06	3.3e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	2.61e-06	3.28e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.6e-06	3.26e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.57e-06	3.23e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.56e-06	3.22e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.54e-06	3.19e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.52e-06	3.17e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.52e-06	3.17e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.5e-06	3.14e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.47e-06	3.1e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.38e-06	2.99e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.37e-06	2.97e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.33e-06	2.93e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.32e-06	2.91e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.31e-06	2.9e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.29e-06	2.87e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.25e-06	2.82e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.21e-06	2.78e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.2e-06	2.77e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.2e-06	2.76e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.18e-06	2.73e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	2.04e-06	2.57e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	1.94e-06	2.44e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.92e-06	2.41e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.89e-06	2.37e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.88e-06	2.36e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.76e-06	2.21e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.73e-06	2.17e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.67e-06	2.1e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.65e-06	2.07e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.65e-06	2.07e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.62e-06	2.04e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.51e-06	1.9e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	1.46e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.59e-07	9.53e-06	CbGpPWpGaD
